Home Cart Sign in  
Chemical Structure| 1395084-25-9 Chemical Structure| 1395084-25-9

Structure of MS436
CAS No.: 1395084-25-9

Chemical Structure| 1395084-25-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

MS436, a diazobenzene-based small compound, is an inhibitor of BRD4 bromodomains with Ki values of 30-50 nM.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of MS436

CAS No. :1395084-25-9
Formula : C18H17N5O3S
M.W : 383.42
SMILES Code : O=S(C1=CC=C(/N=N/C2=CC(C)=C(O)C=C2N)C=C1)(NC3=NC=CC=C3)=O
MDL No. :MFCD27992062
InChI Key :DZTGIRNXWSZBIM-UHFFFAOYSA-N
Pubchem ID :135566899

Safety of MS436

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of MS436

epigenetics

Isoform Comparison

Biological Activity

Target
  • BET

    BRD4 (2), Ki:0.34 μM

    BRD4 (1), Ki:<0.085 μM

In Vitro:

Cell Line
Concentration Treated Time Description References
Primary human hepatocytes (PHH) 10 μM 4 days Evaluation of MS436's antiviral effect in primary human hepatocytes, results showed significant inhibition of HBV RNA transcription and DNA replication Antiviral Res. 2023 Mar;211:105552.
HepG2-NTCP 10 μM 4 days Evaluation of MS436's antiviral effect in HBV infection system, results showed significant reduction in HBV RNA transcription and cccDNA levels Antiviral Res. 2023 Mar;211:105552.
HepAD38 10 μM 4 days Validation of MS436's inhibitory effect on cccDNA transcription, results showed significant reduction in cccDNA transcriptional activity Antiviral Res. 2023 Mar;211:105552.
HepBHAe82 10 μM 4 days Screening for compounds inhibiting HBV cccDNA transcription, MS436 showed significant inhibition of cccDNA transcription Antiviral Res. 2023 Mar;211:105552.
Murine macrophage RAW264.7 cells 0.28 to 50000 nM 24 hours Evaluated LPS-induced IL-6 and NO levels, MS436 showed profound inhibitory activity J Med Chem. 2013 Nov 27;56(22):9251-64.
Murine macrophage RAW264.7 cells up to 100 µM 24 hours Assessed cytotoxicity on cell growth and proliferation, showing stable cell viability J Med Chem. 2013 Nov 27;56(22):9251-64.
Primary alveolar macrophages (PAMs) 40 μM 24 hours Evaluate the cytotoxicity of MS436 on PAMs, showing significant cytotoxic effects at 40 μM concentration. Microbiol Spectr. 2022 Aug 31;10(4):e0241921.
Mouse fibroblasts 5 μM 6 days Evaluate the inhibitory effect of MS436 on telomere elongation, results showed that MS436 inhibited telomere elongation in a dose-dependent manner. Nucleic Acids Res. 2017 Aug 21;45(14):8403-8410.
293TREx/FRT cells 25 μM 48 hours Evaluate the effect of MS436 on telomerase activity, results showed that MS436 did not affect telomerase activity or processivity. Nucleic Acids Res. 2017 Aug 21;45(14):8403-8410.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.61mL

0.52mL

0.26mL

13.04mL

2.61mL

1.30mL

26.08mL

5.22mL

2.61mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories